Claudio Mauro: The Protective Role of Hyodeoxycholic Acid in Liver Cancer
Claudio Mauro, Professor of Metabolism and Inflammation at University of Birmingham, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Molecular Biomedicine, adding:
“One of the greatest opportunities in academia is to contribute to form the next generation of scientists.
Four of my former PhD students and postdocs are now junior PIs.
Today a new paper co-authored with one of them, Kenneth Cheung (Hong Kong Baptist University), has come out and makes me very proud.
In it, we show an epigenetic/metabolic mechanism of hyodeoxycholic acid-mediated protection from hepatocellular carcinoma.”
Title: HDCA suppresses exosomal lncRNA MSTRG171708 release to inhibit Treg-mediated immunometabolism in hepatocellular carcinoma
Authors: Feng Yang, Wenqiong Huang, Chongkai Fang, Chong Zhong, Chaoyuan Huang, Meijun Liu, Zongzhen Meng, Xiaoli Chen, Claudio Mauro, Aiping Lyu, Kenneth C. P. Cheung
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 27, 2026, 16:28Rose Agor: Celebrating Two New Publications in Haematology Research
-
Oct 27, 2026, 16:21Pregnancy and Thrombosis-What Clinicians Need to Know – World Thrombosis Day
-
Oct 27, 2026, 16:13Lesley Van Wyk: DIC vs TTP vs HUS – The Key Diagnostic Clues
-
Oct 27, 2026, 16:02Ahmad G. Alzahrani: AF and Vascular Risk Factors – Should We Add Antiplatelet Therapy?
-
Oct 27, 2026, 16:02Iron Deficiency and Thrombocytosis: How Iron Availability Shapes Hematopoietic Lineage Decisions
-
Oct 27, 2026, 15:46Christiane Berger-Schaffitzel: New PhD Project Explores Snake Venom and Haemostasis
-
Oct 27, 2026, 13:51Muhammed Hajmusa: ESMO 2026 Highlights the Challenge of Anticoagulation in ROS1-Positive Lung Cancer
-
Oct 27, 2026, 13:39Luca Galassi: Retrieved Venous Thrombi as a Tool for Predicting Post-Thrombotic Syndrome
-
Oct 27, 2026, 11:43Tareq Abadl: Hidden Interferences Behind Unexpected Laboratory Results